September 17, 2020
“Aquestive Therapeutics (AQST)… All in all, other analysts echo Moussatos’ sentiment. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $18.67, the upside potential comes in at 136%…… Continue Reading…
September 17, 2020
“Akero Therapeutics (AKRO)… Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target,… Continue Reading…
September 11, 2020
“Houghton Mifflin (HMHC)… Based on all of the above, Warmington rates HMHC an Overweight along with a $5 price target. Should his thesis play out, a potential twelve-month gain of 121% could be in the cards… Gap (GPS)… It should… Continue Reading…
Recent Comments